Skip to main content

Table 3 Metabolic findings after clinical intervention

From: Aggressive clinical approach to obesity improves metabolic and clinical outcomes and can prevent bariatric surgery: a single center experience

 

Baseline

After intervention

Change

TG (mg/dL)

177.4

81.0

−96.4 (−54.3%; p < 001)

LDL (mg/dL)

118.1

98.8

−19.3 (−26.3%; p < 0.05)

ALT (U/L)

52.9

27.8

−25.1 (−47.4%; p < 0.001)

GGT (mg/dL)

47.8

15.2

−32.6 (−68.2%; p < 0.001)

Basal insulin (μIU/mL)

23.1

7.9

−15.2 (−65.8%; p < 0.001)

Fasting glucose (mg/dL)

91.4

77.5

−13.9 (−15.2%; p < 0.001)

HOMA-IR

5.21

1.51

−3.7 (−70.8%; p < 0.001)

Uric acid (mg/dL)

7.1

5.7

−1.4 (−19.7%; p < 0.001)

CRP (mg/L)

0.73

0.39

−0.34 (−46.6%; p < 0.001)

HbA1c (%)

5.87

5.15

−0.72 (−13.6%; p < 0.001)